The Zoster Shield Immunization Package (RZV) is a vaccine designed to protect against shingles (herpes zoster), a painful rash caused by the reactivation of the varicella-zoster virus. The vaccine, commonly known as Recombinant Zoster Vaccine (RZV) or Shingrix, is recommended for adults aged 50 years and older to reduce the risk of developing shingles and its complications, such as long-lasting nerve pain (postherpetic neuralgia).

Above 50 Koramangala
Buy Now
₹ 11600
clinic_pic

Zoster Shield Immunization Package (RZV)

Above 50 Koramangala
₹ 11600

Benefits of Zoster Shield Immunization Package (RZV)

  1. Highly Effective: Provides over 90% protection against shingles, significantly reducing the risk of developing the disease.
  2. Reduces Complications: Lowers the risk of postherpetic neuralgia, a common and often severe complication of shingles that causes prolonged nerve pain.
  3. Long-Lasting Immunity: Offers long-term protection, maintaining efficacy for many years after vaccination.
  4. Suitable for Older Adults: Recommended for adults aged 50 years and older, including those with weakened immune systems, to protect against shingles.
  5. Safe and Well-Tolerated: Demonstrated to be safe with manageable side effects, such as mild injection site reactions, ensuring widespread use and acceptance.

Frequently Asked Questions

It is recommended for adults aged 50 years and older, as well as those with weakened immune systems, to prevent shingles and its complications.
 

The vaccine is given in two doses, typically 2 to 6 months apart.
 

Yes, it is considered safe, with common side effects including soreness at the injection site, fatigue, muscle pain, and mild fever. Severe side effects are rare.
 

Yes, even if you have had shingles, the vaccine is recommended to help prevent future occurrences.
 

Postherpetic neuralgia (PHN) is a complication of shingles characterized by long-lasting nerve pain. The vaccine significantly reduces the risk of developing PHN.

₹ 11600